45th Annual Northeast Bioengineering Conference

21st Century Opportunities in Biomedical Engineering:
Impacting Healthcare from the Clinic to Industry

Free Shuttle Service
No need for an Uber or Lyft!  The NEBEC will offer shuttle service to the conference site from the Hyatt hotel,
New Brunswick train station, Edison train station, and Biomedical Engineering building throughout the entire conference.

Submissions Start: January 2, 2019
Deadline: February 22, 2019


Areas for Submission:

  • Biomaterials
  • Molecular and Cellular Bioengineering
  • Medical Instrumentation
  • Global Health
  • Regenerative Medicine/Tissue Engineering
  • Biomedical Imaging
  • Biomechanics
  • Brain Health/NeuroEngineering
  • Micro/Nanodevices
  • Biomanufacturing
  • Nutrition/Health
  • Stem Cells/Gene Editing
  • Biosystems Engineering Rehabilitation
  • Cancer Biology

Separately, we will also accept one-page PowerPoint descriptions for our Business Pitch Competition.

Our Sponsors

Rutgers University

Healthcare Institute of New Jersey (HINJ)
Sponsorship Level - Sponsored Session

MYOS RENS Technology Inc.
Sponsorship Level - "Best Poster Award" Sponsor

Brown University

Drexel University




Springer Nature Publishing



March 20 & 21, 2019
Symposium on Emerging Challenges in Tissue Engineering and Regenerative Medicine
As part of the newly established "Initiative for Materials Research at Rutgers University" (iMR@RU), the New Jersey Center for Biomaterials has organized the "Symposium on Emerging Challenges in Tissue Engineering and Regenerative Medicine." This event focuses on the pathway from Discovery and Innovation to Translation. A national team of speakers highlights important trends and exciting new directions in Tissue Engineering. In addition, the symposium focuses on funding opportunities presented by the NIH and DoD, as well as ways to secure funding for industry-academia collaborations. Examples of industry-inspired research demonstrate that collaborations with industry can have high scientific and societal impact. The symposium concludes with an overview of the "Advanced Regenerative Manufacturing Institute" (ARMI/BioFab) and presentations highlighting the work of the FDA in regulating regenerative medicine therapies.   DETAILS & REGISTRATION

© Copyright 2007-2019 Northeast Bioengineering Conference. All rights reserved.